Publicaciones en colaboración con investigadores/as de Universidad de Castilla-La Mancha (29)

2020

  1. Can Hyperspectral Images be used to detect Brain tumor pixels and their malignant phenotypes?

    2020 35th Conference on Design of Circuits and Integrated Systems, DCIS 2020

  2. Pretreatment inflammatory indices predict Bevacizumab response in recurrent Glioma

    Cancer Drug Resistance, Vol. 3, Núm. 3, pp. 623-635

2019

  1. Correction to: Morphological MRI-based features provide pretreatment survival prediction in glioblastoma (European Radiology, (2019), 29, 4, (1968-1977), 10.1007/s00330-018-5758-7)

    European Radiology

  2. Morphological MRI-based features provide pretreatment survival prediction in glioblastoma

    European Radiology, Vol. 29, Núm. 4, pp. 1968-1977

2018

  1. A three-dimensional computational analysis of magnetic resonance images characterizes the biological aggressiveness in malignant brain tumours

    Journal of the Royal Society Interface, Vol. 15, Núm. 149

  2. Intratumoral heterogeneity in 18F-FDG PET/CT by textural analysis in breast cancer as a predictive and prognostic subrogate

    Annals of Nuclear Medicine, Vol. 32, Núm. 6, pp. 379-388

  3. Predictive and prognostic potential of volume-based metabolic variables obtained by a baseline 18F-FDG PET/CT in breast cancer with neoadjuvant chemotherapy indication

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 37, Núm. 2, pp. 73-79

  4. Regulation of the oxidative balance with coenzyme Q10 sensitizes human glioblastoma cells to radiation and temozolomide

    Radiotherapy and Oncology, Vol. 128, Núm. 2, pp. 236-244

2017

  1. A mathematical model describes the malignant transformation of low grade gliomas: Prognostic implications

    PLoS ONE, Vol. 12, Núm. 8

  2. Análisis de textura con 18f-FDG PET/TC y su relación con variables de SUV, volumétricas e inmunohistoquímicas en cáncer de mama

    Revista Española de Medicina Nuclear e Imagen Molecular. 36.º Congreso de la Sociedad Española de Medicina Nuclear e Imagen Molecular Palma de Mallorca, 24-26 Octubre 2017

  3. Glioblastoma on a microfluidic chip: Generating pseudopalisades and enhancing aggressiveness through blood vessel obstruction events

    Neuro-Oncology, Vol. 19, Núm. 4, pp. 503-513

  4. Glioblastoma: Pre-treatment geometry and texture of postcontrast T1 MRI matter

    2016 Conference on Design of Circuits and Integrated Systems, DCIS 2016 - Proceedings

  5. Glioblastoma: does the pre-treatment geometry matter? A postcontrast T1 MRI-based study

    European Radiology, Vol. 27, Núm. 3, pp. 1096-1104

  6. Lack of robustness of textural measures obtained from 3D brain tumor MRIs impose a need for standardization

    PLoS ONE, Vol. 12, Núm. 6

  7. Metabolic Tumor Burden Assessed by Dual Time Point [18F]FDG PET/CT in Locally Advanced Breast Cancer: Relation with Tumor Biology

    Molecular Imaging and Biology, Vol. 19, Núm. 4, pp. 636-644

  8. Non-standard radiotherapy fractionations delay the time to malignant transformation of low-grade gliomas

    PLoS ONE, Vol. 12, Núm. 6

  9. Relación entre las variables SUV, volumétricas y de textura en 18f-FDG PET/TEC de doble fase en cáncer de mama

    36.º Congreso de la Sociedad Española de Medicina Nuclear e Imagen Molecular Palma De Mallorca, 24-26 Octubre 2017

  10. Textural features and SUV-based variables assessed by dual time point 18F-FDG PET/CT in locally advanced breast cancer

    Annals of Nuclear Medicine, Vol. 31, Núm. 10, pp. 726-735

2016

  1. Geometrical measures obtained from pretreatment postcontrast T1 weighted mris predict survival benefits from bevacizumab in glioblastoma patients

    PLoS ONE, Vol. 11, Núm. 8

  2. Hypoxia in gliomas: Opening therapeutical opportunities using a mathematical-based approach

    Advances in Experimental Medicine and Biology (Springer New York LLC), pp. 11-29